
|Videos|November 6, 2015
Safeguards Pharmacies Can Put in Place to Avoid Issues with Controlled Substance Prescriptions
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some safeguards independent pharmacies can implement to avoid issues with controlled substance prescriptions.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some safeguards independent pharmacies can implement to avoid issues with controlled substance prescriptions.
This video was recorded at the National Community Pharmacists Association's (NCPA) 2015 Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
5

















































































































































































































